GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » ROC (Joel Greenblatt) %

Ypsomed Holding AG (XSWX:YPSN) ROC (Joel Greenblatt) % : 19.16% (As of Sep. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG ROC (Joel Greenblatt) %?

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Ypsomed Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 19.16%.

The historical rank and industry rank for Ypsomed Holding AG's ROC (Joel Greenblatt) % or its related term are showing as below:

XSWX:YPSN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.05   Med: 14.68   Max: 32.3
Current: 20.3

During the past 13 years, Ypsomed Holding AG's highest ROC (Joel Greenblatt) % was 32.30%. The lowest was 2.05%. And the median was 14.68%.

XSWX:YPSN's ROC (Joel Greenblatt) % is ranked better than
71.65% of 850 companies
in the Medical Devices & Instruments industry
Industry Median: -0.965 vs XSWX:YPSN: 20.30

Ypsomed Holding AG's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -21.70% per year.


Ypsomed Holding AG ROC (Joel Greenblatt) % Historical Data

The historical data trend for Ypsomed Holding AG's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG ROC (Joel Greenblatt) % Chart

Ypsomed Holding AG Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.41 2.71 2.05 6.83 13.67

Ypsomed Holding AG Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.23 9.60 9.04 20.39 19.16

Competitive Comparison of Ypsomed Holding AG's ROC (Joel Greenblatt) %

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's ROC (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's ROC (Joel Greenblatt) % falls into.



Ypsomed Holding AG ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(93.336 + 57.704 + 17.01) - (29.96 + 0 + 72.028)
=66.062

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(95.691 + 69.506 + 31.844) - (35.734 + 0 + 286.544)
=-125.237

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Ypsomed Holding AG for the quarter that ended in Sep. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Sep. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=80.82/( ( (379.587 + max(66.062, 0)) + (397.764 + max(-125.237, 0)) )/ 2 )
=80.82/( ( 445.649 + 397.764 )/ 2 )
=80.82/421.7065
=19.16 %

Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (XSWX:YPSN) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Ypsomed Holding AG ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (XSWX:YPSN) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (XSWX:YPSN) Headlines

No Headlines